All In Biotech

Free tool

FAERS Monitor: Xadago

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 207145 or its brand name (Xadago, Safinamide Mesylate). Reports on generic versions are filed under their own applications.

Reports

1,386

Serious

1,086

78% of reports

Hospitalization

597

Death reported

175

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • fall177
  • dyskinesia162
  • hallucination159
  • death108
  • on and off phenomenon108
  • gait disturbance104
  • parkinson^s disease98
  • drug ineffective95
  • tremor89
  • fatigue82
  • freezing phenomenon78
  • somnolence73
  • anxiety69
  • confusional state69
  • nausea69

Reports by year received

View as table
YearReports
201624
201757
2018112
2019152
2020158
2021144
2022142
2023117
2024136
2025173
2026171

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,052,773 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

FDA's data service returned an error (400). The numbers below may be missing or incomplete.
ReactionReportsPRR95% CI lowerChi-squared
freezing phenomenonSignal78326.6262.624,470
on and off phenomenonSignal108301.1250.731,386
dyskinesiaSignal16260.752.59,438
hallucinationSignal15932.127.74,764
gait disturbanceSignal1048.26.9661
tremorSignal898.16.7554
fallSignal1778.17.01,107
confusional stateSignal696.55.2317
somnolenceSignal735.54.4267
anxietySignal693.72.9134
death1081.91.647
fatigue821.61.318
nausea691.31.15
drug ineffective951.10.91
parkinson^s disease980.00.01,473,435

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.